Coherent Biopharma key facts
as of Oct 2026- Developer of biopharmaceutical drugs designed to advance targeted therapies for cancer and other serious diseases.
- It has raised $130.0M; the latest was Later Stage VC in Mar 2026.
- Notable investors include Hefei Industry Investment Group, Hefei Hi-Tech VC, V-Capital, Shanghai Alliance Investment, Suzhou Yuanfeng Capital Management — 10 tracked in total.
- 11 institutional filers report fund marks on Coherent Biopharma across 100 filings.
- Status: Privately Held (backing).
- ·Watch Coherent Biopharma: the Monday email on marks, rounds and moves
Institutional fund marks on Coherent Biopharma
11 filers · latest Jul 202611 SEC-registered funds reported 100 fair-value marks on Coherent Biopharma between Apr 2025 and Jul 2026. Filer-level marks and implied $/share are available to Pro members.
Membership and data by Private Market View
Coherent Biopharma funding rounds
No funding rounds for Coherent Biopharma are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Recent activity
In the last 90 days, Coherent Biopharma's record added 9 institutional fund marks (latest period Jul 2026).
Institutional holders and vehicles
11 SEC-registered funds reported 100 fair-value marks on Coherent Biopharma between Apr 2025 and Jul 2026, in their N-PORT filings. Filer-level marks and implied per-share values are available to Pro members.
Coherent Biopharma investors
10 investors are on record for Coherent Biopharma, including Hefei Industry Investment Group, Hefei Hi-Tech VC, V-Capital and Shanghai Alliance Investment.
About Coherent Biopharma
Developer of biopharmaceutical drugs designed to advance targeted therapies for cancer and other serious diseases. The company offers bi-targeting drug conjugate technology, proprietary ligand discovery platforms and targeted payload delivery mechanisms, enabling healthcare researchers and oncology patients to access precision therapeutics with improved cellular targeting and therapeutic efficacy
- Sector
- Healthcare
- HQ
- Suzhou, China
- Employees
- 100
- Website
- coherentbio.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.